CELL-MET member Bioventus advances bone formation for improved healing

Bioventus, a CELL-MET member, has developed a next-generation chimeric bone morphogenetic protein BMP/carrier engineered for more potent/efficaious bone formation, that acts as an adjunct to surgical repair of severe open fractures requiring augmented healing. This research article shows that a BMP/activin A chimera is superior to native BMPs and induces bone repair in nonhuman primates.